Lokavant, which provides a data analytics platform for clinical trials, raised $21 million in a funding round led by Edison Partners.
Roivant Sciences, which builds health tech and biotech companies called "Vants," participated in the raise. Lokavant was incubated at Roivant and piloted its platform with some of the company's other biotech ventures.
As part of the fundraise, Gregg Michaelson,...